glp 1 and vision issues π Optometrists are warning GLP-1 drugs may pose these types of rare risks π β¬οΈ Details in comments The Impact of GLP-1 Receptor
Description
Its easy to become fixated on the very small and still-debated risk of a medication while ignoring the much larger and clear risks of foregoing treatment
My GLP-1 Journey: A Complete Tracking Log
| Gpl1 recipes, Healthy smoothies, Drinks smoothies
Participants received diet (500kcaldeficit per day) and exercise counseling during 2-week run-in, before being randomly assigned (with a telephone or web-based system) to once-daily subcutaneous liraglutide (1.2, 1.8, 2.4 or 3.0mg, n=9095), placebo (n=98) or open-label orlistat (120mg 3, n=95)
